ロード中...
Pharmacokinetics of Rytary(®), An Extended-Release Capsule Formulation of Carbidopa–Levodopa
Parkinson’s disease (PD) is a chronic progressive neurological disorder characterized by resting tremor, rigidity, bradykinesia, gait disturbance, and postural instability. Levodopa, the precursor to dopamine, coadministered with carbidopa or benserazide, aromatic amino acid decarboxylase inhibitors...
保存先:
| 出版年: | Clin Pharmacokinet |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5563351/ https://ncbi.nlm.nih.gov/pubmed/28236251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-017-0511-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|